Exon junction complexes regulate osteoclast-induced bone resorption by influencing the NFATc1 m6A distribution through the “shield effect”

Bao Sun , Jin-Gang Yang , Zhe Wang , Zheng Wang , Wei Feng , Xing Li , Sheng-Nan Liu , Jiang Li , Ya-Qin Zhu , Ping Zhang , Wei Wang

Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (3) : e70266

PDF
Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (3) : e70266 DOI: 10.1002/ctm2.70266
RESEARCH ARTICLE

Exon junction complexes regulate osteoclast-induced bone resorption by influencing the NFATc1 m6A distribution through the “shield effect”

Author information +
History +
PDF

Abstract

•METTL14 controls osteoclast-mediated bone resorption by means of the methylation (4249 A) of the NFATc1 gene during osteoclast differentiation.

•Exon junction complexes (EJCs) protect the remaining methylation sites of the NFATc1 gene (located in the inner exon fragment of 50–200 nt) from hypermethylation and degradation.

•The “shield effect” disappears when the exon fragment is extended to 300 nt. Downstream, YTHDF2 induced the degradation of hypermethylation NFATc1 transcripts without site restriction.

Keywords

exon junction complexes / m6A distribution characteristics / osteoclast / osteoporosis / shield effect

Cite this article

Download citation ▾
Bao Sun,Jin-Gang Yang,Zhe Wang,Zheng Wang,Wei Feng,Xing Li,Sheng-Nan Liu,Jiang Li,Ya-Qin Zhu,Ping Zhang,Wei Wang. Exon junction complexes regulate osteoclast-induced bone resorption by influencing the NFATc1 m6A distribution through the “shield effect”. Clinical and Translational Medicine, 2025, 15(3): e70266 DOI:10.1002/ctm2.70266

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

AI Summary AI Mindmap
PDF

131

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/